Jones James bought CPIX
December 3, 2025 · Form 4 insider transaction
Jones James bought 18 shares of Cumberland Pharmaceuticals Inc. at $2.25 per share, a transaction worth $40.50. The trade was recorded as l under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 34 days after the transaction.
Direction
Acquired (buy-side)
Shares
18
Price
$2.25
Total value
$40.50
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeL: L
Transaction dateDecember 3, 2025
Filing dateJanuary 6, 2026
Shares owned after44,847
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.